Brittany G. Craiglow

Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata

Milène K. Crispin, Justin Ko, Brittany G. Craiglow et al. · JCI Insight · 2016 · 344 citations · Full text

Medicine, Dermatology, Pharmacology +11

Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients

Lucy Liu, Brittany G. Craiglow, Feng Dai et al. · Journal of the American Academy of Dermatology · 2016 · 342 citations

Medicine, Dermatology, Pharmacotherapy +6

Tofacitinib Citrate for the Treatment of Vitiligo

Brittany G. Craiglow, Brett King · JAMA Dermatology · 2015 · 256 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata

Nekma Meah, Dmitri Wall, Katherine York et al. · Journal of the American Academy of Dermatology · 2020 · 204 citations

Medicine, Dermatology, Cosmetic Dermatology +11

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results

Brett King, Emma Guttman‐Yassky, Elena Peeva et al. · Journal of the American Academy of Dermatology · 2021 · 193 citations · Full text

Medicine, Dermatology, Pharmacology +15